| Financial Year |
March 31 2023 |
| Monetary Funds |
1,984,224,648.42 |
| Held-for-trading Financial Assets |
230,235,722.23 |
| Notes Receivable |
-- |
| Accounts Receivable |
30,008,270.27 |
| Advances to Suppliers |
144,558,547.87 |
| Other Receivables |
87,289,030.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,981,980,330.88 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
8,215,719.20 |
| Total Current Assets |
4,466,512,269.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,010,573,422.53 |
| Investment Properties |
-- |
| Fixed Assetes |
1,099,715,322.15 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
160,311,026.85 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
36,618,117.66 |
| Deferred Income Tax Assets |
36,423,702.91 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
3,599,916,703.58 |
| Total Assets |
8,066,428,973.20 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
1,441,693,238.13 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
91,679,440.81 |
| Taxes Payable |
72,470,067.51 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
118,734,425.67 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
510,964,044.38 |
| Other Current Liabilities |
106,804,787.50 |
| Sub-Total of Current Liabilities |
3,163,921,292.44 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
611,066,469.55 |
| Total Liabilities |
3,774,987,761.99 |
| Paid-In Capital(Or Share Stock) |
1,360,000,000.00 |
| Capital Surplus |
43,743,156.96 |
| Surplus Reserve |
371,311,409.31 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
2,516,386,644.94 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
4,291,441,211.21 |
| Owner's Equity（Stockholder's Equity） |
4,291,441,211.21 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,066,428,973.20 |
